{"id":"https://openalex.org/W1870097366","doi":null,"title":"Visfatin Levels in Iraqi Controlled Diabetic Patients and Uncontrolled Diabetic with Cardiomyopathy","display_name":"Visfatin Levels in Iraqi Controlled Diabetic Patients and Uncontrolled Diabetic with Cardiomyopathy","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W1870097366","mag":"1870097366"},"language":"en","primary_location":{"id":"mag:1870097366","doi":null,"is_oa":false,"landing_page_url":"https://iiste.org/Journals/index.php/JNSR/article/view/23484","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Natural Sciences Research","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111516398","display_name":"Layla K. Ali","orcid":"https://orcid.org/0000-0003-0871-3008","observed_orcids":["https://orcid.org/0000-0003-0871-3008"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Layla K. Ali","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111516398"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0585023,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"12","first_page":"39","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12979","display_name":"Cardiovascular Disease and Adiposity","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/visfatin","display_name":"visfatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/uncontrolled-diabetes","display_name":"uncontrolled diabetes","score":0.9160000085830688},{"id":"https://openalex.org/keywords/diabetic-cardiomyopathy","display_name":"diabetic cardiomyopathy","score":0.9940000176429749},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.625},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.9829999804496765},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9120000004768372},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.9359999895095825},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.6650000214576721},{"id":"https://openalex.org/keywords/cardiovascular-risk-markers","display_name":"cardiovascular risk markers","score":0.39399999380111694}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8774442076683044},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8334423303604126},{"id":"https://openalex.org/C2776553924","wikidata":"https://www.wikidata.org/wiki/Q5270132","display_name":"Diabetic cardiomyopathy","level":4,"score":0.7998467683792114},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.696428120136261},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.6704375743865967},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6326847076416016},{"id":"https://openalex.org/C8243546","wikidata":"https://www.wikidata.org/wiki/Q419074","display_name":"Very low-density lipoprotein","level":4,"score":0.6158721446990967},{"id":"https://openalex.org/C2780541478","wikidata":"https://www.wikidata.org/wiki/Q410020","display_name":"High-density lipoprotein","level":3,"score":0.5307281613349915},{"id":"https://openalex.org/C2779620165","wikidata":"https://www.wikidata.org/wiki/Q28749","display_name":"Low-density lipoprotein","level":3,"score":0.5120899677276611},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.4356363117694855},{"id":"https://openalex.org/C2778797674","wikidata":"https://www.wikidata.org/wiki/Q847583","display_name":"Cardiomyopathy","level":3,"score":0.41222766041755676},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.37592774629592896},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.14962705969810486}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1870097366","doi":null,"is_oa":false,"landing_page_url":"https://iiste.org/Journals/index.php/JNSR/article/view/23484","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Natural Sciences Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1507178887","https://openalex.org/W1968294487","https://openalex.org/W1968744223","https://openalex.org/W1985482335","https://openalex.org/W1989200821","https://openalex.org/W1996082994","https://openalex.org/W2028829631","https://openalex.org/W2071539914","https://openalex.org/W2100732809","https://openalex.org/W2104437296","https://openalex.org/W2116404316","https://openalex.org/W2127509487","https://openalex.org/W2132599454","https://openalex.org/W2134328213","https://openalex.org/W2143327184","https://openalex.org/W2183448014","https://openalex.org/W2187986581","https://openalex.org/W2189372168"],"related_works":["https://openalex.org/W313106659","https://openalex.org/W2998016957","https://openalex.org/W2360218618","https://openalex.org/W1944512328","https://openalex.org/W2126345133","https://openalex.org/W2358130863","https://openalex.org/W2063483673","https://openalex.org/W3170732512","https://openalex.org/W3196630861","https://openalex.org/W2391613613"],"abstract_inverted_index":{"The":[0,27,134,148],"aim":[1],"of":[2,53,62,72,87,183,210],"the":[3,22,181,208],"present":[4],"study":[5,28,178,206],"is":[6,207],"to":[7],"evaluate":[8],"vifatin":[9],"levels":[10,128,159],"in":[11,85,115,126,140,154,168,186],"uncontrolled":[12,16,66,76,187,194,227,230],"diabetic":[13,17,195,228,231],"patients":[14,64,74,189],"and":[15,20,36,78,108,157,202],"with":[18,24,32,65,75,132,146,163,190,232],"cardiomyopathy":[19,79,191,233],"compare":[21],"results":[23,110,149],"healthy":[25,57],"control.":[26],"included":[29],"ninety":[30],"subjects":[31],"aged":[33],"ranged":[34],"(25-40)years":[35],"BMI(<":[37],"25)Kg/m":[38],"2":[39],".These":[41],"were":[42,171],"which":[43,196,211],"divided":[44],"into":[45],"three":[46],"groups":[47],"as":[48,56,80],"follows":[49],":":[50,223],"group":[51,60],"1(G1):consist":[52],"30":[54,63,73],"individuals":[55],"control":[58],"group,":[59],"2(G2),consist":[61],"diabetes":[67],"mellitus":[68],"(DM).":[69],"Group3(G3)":[70],"consist":[71],"DM,":[77],"complication.":[81],"Plasma":[82],"was":[83],"used":[84],"determination":[86],"fasting":[88],"blood":[89],"glucose(FBG)":[90],",lipid":[91],"profile[total":[92],"cholesterol":[93],"(TC),":[94],"triglyceride":[95],"(TG),":[96],"high":[97],"density":[98,101,105],"lipoprotein(HDL),":[99],"low":[100,104],"lipoprotein(LDL),":[102],"very":[103],"lipoprotein(VLDL)],C-reactive":[106],"protein(CRP),insulin":[107],"visfatin.The":[109],"showed":[111,137],"highly":[112,151],"significant":[113,124,138,152,166],"elevation":[114,139,153,167],"FBG,":[116],"TC,":[117],"TG,":[118],"LDL,":[119],"VLDL,":[120],"while":[121],"there":[122],"are":[123],"reduction":[125],"HDL":[127],"when":[129,143,160,173],"G2":[130,162],"compared":[131,145,175],"G1.":[133,164],"results,":[135],"also":[136],"these":[141,169,214],"parameters":[142,170],"G3":[144,174],"G2.":[147],"revealed":[150],"hs-CRP,":[155],"insulin":[156],"visfatin\u00a0":[158],"comparing":[161],"Also":[165],"noticed":[172],"withG2.In":[176],"conclusion,":[177],"found":[179],"that":[180],"concentration":[182],"visfatin":[184,201],"increase":[185],"diabetic\u00a0":[188],"more":[192],"than":[193],"indicate":[197],"positive":[198],"relation":[199],"between":[200],"heart":[203],"diseases.":[204],"This":[205],"first":[209],"has":[212],"investigated":[213],"relationships.":[215],"Keyword":[219],"s":[221],"Visfatin":[225],",":[226],"patients,":[229]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}